Carasent AB (APXZF)
4.303
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Carasent Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 1.083M |
| December 31, 2021 | 1.141M |
| December 31, 2020 | 0.4815M |
| December 31, 2019 | |
| December 31, 2018 | |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 |
| Date | Value |
|---|---|
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 | |
| December 31, 2009 | 1.705M |
| December 31, 2008 | 1.898M |
| December 31, 2007 | 1.073M |
| December 31, 2006 | 0.7724M |
| December 31, 2005 | 0.3139M |
| December 31, 2004 | 0.5125M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| SyntheticMR AB | 0.9463M |
| HealthStream, Inc. | 50.98M |
| Simulations Plus, Inc. (DELISTED) | 6.884M |
| CareView Communications, Inc. | 2.414M |
| DATATRAK International, Inc. | -- |